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1. Introduction
Foot-and-mouth disease (FMD) is an acute, contagious 
viral disease of cloven-hoofed livestock such as cattle, pigs, 
buffalo, sheep and goats. FMD causes severe economic loss 
in developing countries. Seven serotypes (A, O, C, Asia-1, 
and South African Territories 1, 2, and 3) have been identifi ed 
serologically, and multiple subtypes occur within each serotype. 
The foot-and-mouth disease virus (FMDV) consists of a single-
stranded, positive-sense RNA genome of approximately 8500 
bases surrounded by four structural proteins (VP1 [1D], VP2 
[1B], VP3 [1C], and VP4 [1A]) to form an icosahedral capsid. 
The genome also codes for eight non-structural proteins (Lpro, 
2A, 2B, 2C, 3A, 3B, 3Cpro and 3D-RNA dependant RNA 
polymerase) (Grubman and Baxt 2004).
FMD is endemic in India and serotypes A, O and Asia-1 
are prevalent. The predominant serotype reported in India 
is type O, while serotype A has been identifi ed in 10% 
of outbreaks. The uncontrolled movement of animals, 
low vaccination coverage and antigenic variation within 
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and between serotypes are factors that cause problems in 
controlling FMD outbreaks (Azad et al 1995). Extensive 
studies on the genetic and antigenic variation of FMDV 
serotypes O and Asia-1 have been carried out worldwide. 
Unlike serotype O and Asia-1 virus, serotype A isolates have 
shown extensive antigenic variation (Arrowsmith 1975; 
Belwal et al 1986; Belwal et al 1987; Armstrong et al 1994; 
Azad et al 1995; Araujo et al 2002). Several workers (Tosh 
et al 2004; Mittal et al 2005; Jangra et al 2005; Mohapatra 
et al 2008) have studied genetic and antigenic variation in 
Indian FMDV isolates. Continuous monitoring of the disease 
is essential to understand the epidemiology of the virus and 
the mutations that occur over a period of time. Recently, 
Nagendrakumar et al (2006) reported the need for continuous 
monitoring of the isolates in order to update the primers and 
probes used for the detection of Indian FMDV isolates. The 
present study reports the analysis of the leader protease (Lpro) 
and P1 coding sequences of FMDV type A virus isolated 
from various parts of the country between 1968 and 2005.
2. Materials and methods
2.1 Viruses
Forty-six FMDV serotype A isolates from different regions 
of India collected during the period 1968–2005 available 
with the virus repository of the FMDV Laboratory, Indian 
Immunologicals Limited, Hyderabad were used in this 
study (table 1). Sequences of Indian and exotic serotype A 
virus available in the GenBank (Jangra et al 2005; Carrillo 
et al 2005) and sequences of two type A Indian isolates 
(Nick Knowles, EF 208771 and EF 208772) including eight 
vaccine strains (A IND 17/77, A IND 17/82, A IND 7/82, A 
IVRI, A
5
 FRANCE 60, A
10
 HOLLAND 42, A
22
 IRAQ 64 and 
A
24
 BRAZIL 55) were included for comparison.
2.2 Primary bovine thyroid cell cultures
Primary bovine thyroid (BTy) cell cultures were prepared using 
thyroid glands harvested from day-old male calves as per the 
procedure described in Freshney (2004). The thyroid glands 
were harvested, dissected and trypsinized using 0.5% trypsin 
solution in 0.04 M phosphate buffer. The cells were seeded at 
a rate of 1x106 cells/ml in 5 cm2 NunclonTM polystyrene tubes 
with a fl at side (Nunc®, Denmark) with cell growth medium 
containing 10% adult bovine serum. Once the monolayers 
were formed, the culture was used for virus isolation.
2.3 BHK-21 cells
Baby hamster kidney cell line (BHK-21) maintained 
as monolayers by the tissue culture laboratory, Indian 
Immunologicals Limited, Hyderabad was used for isolation 
of the virus as well as preparation of virus master banks.
2.4 HELY cell growth medium
HELY cell growth medium (pH 7.4–7.6) was used for 
cultivating primary BTy cells. Growth medium was prepared 
by mixing 800 ml of Hanks BSS medium containing 0.2% 
yeast extract with 200 ml of 10% Eagle medium. Tissue 
culture-grade calf serum (10%, Selborne, Australia) and 6 ml 
of 4.4 M sodium bicarbonate were added. Sterility testing was 
carried out and the medium was stored at 4–8ºC until use.
2.5 Virus maintenance medium with (1%) serum (VMMS)
Virus maintenance medium was prepared by adding 10 ml 
of adult bovine serum, 50 ml of 4.4 M sodium bicarbonate 
solution and 40 ml of sterile distilled water to 900 ml of 
Glasgow Eagle medium containing Earle salts. The sterility 
of the medium was confi rmed by inoculation into soyabean 
casein digest medium and tryptose broth for 7 days. Media that 
passed the sterility test were stored at 4–8ºC until use.
2.6 Reagents for genome amplifi cation and sequencing
The viral RNA was isolated using TRIzol® Reagent 
(Invitrogen, USA) according to the manufacturer’s 
instructions. The FMDV genome targets Lpro and capsid-
coding P1 regions were reverse transcribed using the 
Thermoscript® Reverse Transcription System (Invitrogen, 
USA). The target in the genome was amplifi ed by polymerase 
chain reaction (PCR) using a Platinum Taq PCR system 
for Long Templates (Invitrogen, USA). The target was 
sequenced using an ABI Prism BigDye Cycle Sequencing 
Ready Reaction kit v 3.1 as per the manufacturer’s protocol 
on an ABI Prism Automatic Cycle Sequencer.
2.7 Isolation and adaptation of the virus
Epithelial samples from the tongue and feet were processed 
in 0.04 M phosphate buffer and made up as a 10% 
suspension. The suspension was inoculated on the primary 
thyroid cell monolayer cultures. The cultures were observed 
for 24–48 h for the appearance of a cytopathic effect. Virus 
typing was done (Hamblin et al 1984) and type A viruses 
adapted to BHK-21 cells were used in this study.
2.8 Preparation of cDNA by reverse transcription
The total RNA extracted (5 μl) was subjected to reverse 
transcription (fi nal reaction volume of 20 μl) using the 
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Table 1. List of viruses used in the study and their place of origin
S. No. Virus identifi cation Place of origin Year of isolation GenBank accession no:
District and State Country 1D region Lpro region
1 A5 IVRI - HOLLAND 1942 EF120378 -
2 A IND 2/68 Pune, Maharashtra INDIA 1968 EF120380 EF108183
3 A IND 5/68 Calcutta, West Bengal INDIA 1968 - EF108185
4 A IND 1/70 Lucknow, Uttar Pradesh INDIA 1970 EF120381 -
5 A IND 3/73 Roorkee, West Bengal INDIA 1973 EF120382 -
6 A IND 8/76 North Arcot, Tamil Nadu INDIA 1976 EF120383 -
7 A IND 19/76 Dehradun, Uttar Pradesh INDIA 1976 - EF108190
8 A IND 3/77 Haringhatta, West Bengal INDIA 1977 - EF108184
9 A IND 17/77 West Bengal INDIA 1977 - -
10 A IND 54/79 Tirunelveli, Tamil Nadu INDIA 1979 - EF108195
11 A IND 57/79 Dharmapuri, Tamil Nadu INDIA 1979 EF120385 EF108196
12 A IND 73/79 Mehboob Nagar, Andhra Pradesh INDIA 1979 - EF108197
13 A IND 85/79 Bombay, Maharashtra INDIA 1979 - EF108198
14 A IND 86/79 Ahmedabad, Gujarat INDIA 1979 - EF108199
15 A IND 25/81 Ahmedabad, Gujarat INDIA 1981 - EF108193
16 A IND 7/82 Kheda, Gujarat INDIA 1982 - EF108186
17 A IND 16/82 Jind, Haryana INDIA 1982 - EF108187
18 A IND 17/82 Bilaspur, Himachal Pradesh INDIA 1982 - EF108189
19 A IND 20/82 Jammu, Jammu & Kashmir INDIA 1982 - EF108191
20 A IND 22/82 Not known INDIA 1982 - EF108192
21 A IND 26/82 Not known INDIA 1982 - EF108194
22 A APA 25/84 Anantapur, Andhra Pradesh INDIA 1984 - EF108200
23 A GUM 33/84 Mehsana, Gujarat INDIA 1984 EF120386 EF108208
24 A APN 41/84 Nellore, Andhra Pradesh INDIA 1984 - EF108201
25 A ORS 66/84 Sambalpur, Orissa INDIA 1984 EF120379 EF108209
26 A ORS 75/88 Sambalpur, Orissa INDIA 1988 EF120387 EF108210
27 A GUA 24/91 Ahmedabad, Gujarat INDIA 1991 EF120389 -
28 A GUA 21/91 Ahmedabad, Gujarat INDIA 1991 EF120390 -
29 A GUA 27/91 Ahmedabad, Gujarat INDIA 1991 EF120388 -
30 A MAT 18/93 Thane, Maharashtra INDIA 1993 EF120391 -
31 A MAN 47/94 Nagpur, Gujarat INDIA 1994 - -
32 A TNAn 60/94 Arakkonam, Tamil Nadu INDIA 1994 EF120393 EF108211
33 A TNC 71/94 Chennai, Tamil Nadu INDIA 1994 EF120394 EF108182
34 A GUK 14/95 Kheda, Gujarat INDIA 1995 EF120395 -
35 A BIM 46/95 Mirzapur, Bihar INDIA 1995 EF120396 EF108207
36 A HAH 51/95 Hissar, Haryana INDIA 1995 EF120397 -
37 A RAJ 21/96 Jaipur, Haryana INDIA 1996 EF120398 -
38 A APG 35/96 Guntur, Andhra Pradesh INDIA 1996 - -
39 A HAH 14/00 Hissar, Haryana INDIA 2000 EF120399 -
40 A APR 51/01 Ranga Reddy, Andhra Pradesh INDIA 2001 EF120400 -
41 A MEU 19/03 Umroi, Meghalaya INDIA 2003 EF120401 -
42 A WBJ 30/04 Jalpaiguri, West Bengal INDIA 2004 - -
Thermoscript® Reverse Transcription System (Invitrogen, 
USA). For each sample, reverse transcription was carried 
out in duplicate using negative sense primer P33 (CGG 
TTT GGG ACC ATG TTC GA, 2B region of the genome; 
Knowles and Samuel 1995). The two sets of cDNA were 
used for PCR amplifi cation as duplicate reactions.
2.9 Amplifi cation of Lpro-coding region ‘L’ and capsid-
coding region ‘P1’ by PCR
The cDNA (5 μl) was subjected to PCR reaction using the 
Platinum Taq PCR System for Long Templates (Invitrogen, 
USA) with primer pairs LO1F (GTC CCC CAG TTT AAA 
AAG CTT, positive sense primer, 5’ untranslated region 
[UTR]; Roberts and Belsham 1995) and NK72 (GAA 
GGG CCC AGG GTT GGA CTC, negative sense primer, 
2B region; Knowles and Samuel 1995) for amplifying the 
LP1 region. Primer pairs A-1C612 (TAG CGC CGG CAA 
AGA CTT TAG, positive sense primer; Vangrysperre and de 
Clercq 1996) and NK61 (GAC ATG TCC TCC TGC ATC 
TG, negative sense primer; Knowles and Samuel 1995) were 
used to amplify the complete 1D region, while primer pairs 
DH6 (TTG TTC TGA GTG TTG GTT GTG TG, positive 
sense primer; Sabarinath 2001) and NK61 were used to 
amplify the complete capsid-coding P1 region.
2.10 Analysis of reverse transcriptase-polymerase chain 
reaction product
The reverse transcriptase-polymerase chain reaction (RT-
PCR) products obtained were analysed on a 0.8% agarose 
gel with 0.01% ethidium bromide under ultraviolet (UV) 
illumination and documented using a gel documentation 
system (BioRad, USA). Positive amplifi cation was the 
appearance of a ~3 kbp PCR product for the LP1 region, 
~2.1 kbp PCR product for the complete P1 region and ~900 
bp PCR product for the 1D region.
2.11 Purifi cation of the RT-PCR product
The RT-PCR products were run on a 1.5% low-melting 
agarose gel and the respective bands were cut and removed. 
The PCR product from the excised portion of the gel was 
eluted using Qiaquick® Gel Extraction Kit (Qiagen, USA) 
and reconstituted in 30 μl of elution buffer. 
2.12 Sequencing of RT-PCR products
The eluted RT-PCR products were subjected to direct 
cycle sequencing with different sets of forward and reverse 
sequencing oligonucleotide primers using the BigDye 
Terminator Cycle Sequencing Ready Reaction kit v3.1 
(Applied Biosystems, USA) as per the manufacturer’s 
protocol on an automatic cycle sequencer (ABI Prism, 
Applied Biosystems, USA).
2.13 Genomic comparison by phylogenetic analysis
The Lpro and VP1 coding sequences (complete 1D region) 
were aligned using the ClustalW 1.8x program (Thompson 
et al 1994). Manual editing at codon positions 153 and 155 
was done to accommodate for the reported deletion of amino 
acids in some of the exotic virus sequences referred to. A 
phylogenetic neighbour-joining (NJ) tree was constructed 
(bootstrap replicates = 1000) using Mega 3.1 (Kumar et 
al 2004). The genetic heterogeneity of the viruses has been 
defi ned as genetic groups if the genetic relationship has 
<15% nucleotide divergence (Vosloo et al 1992; Samuel 
and Knowles 2001; Tosh et al 2002a) and as lineage if 
the genetic relationship has <7.5% nucleotide divergence 
(Mohapatra et al 2002).
Phylogenetic analysis using a Bayesian algorithm 
(MrBayes) was also drawn using the software described 
by Huelsenbeck and Ronquist (2001). The maximum 
likelihood model employed 2 substitution types (“nst = 
2”), with base frequencies set to fi xed values (“statefreqpr 
= fi xed [equal]”). Rate variation across sites was modelled 
using a gamma distribution (“rates = gama”). The Markov 
Chain Monte Carlo (MCMC) search was run with 4 chains 
for 5 000 000 generations, with trees being sampled every 
1000 generations (the fi rst 10 000 trees were discarded as 
“burnin”). The topology of the consensus tree was viewed 
using Treeview (Page 1996). 
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Table 1 (Continued)
S. No. Virus identifi cation Place of origin Year of isolation GenBank accession No:
District and State Country 1D region Lpro region
43 A APS 44/05 Srikkakulam, Andhra Pradesh INDIA 2005 EF120402 EF108202
44 A APS 50/05 Srikkakulam, Andhra Pradesh INDIA 2005 - EF108203
45 A APS 55/05 Srikkakulam, Andhra Pradesh INDIA 2005 - EF108204
46 A APS 66/05 Srikkakulam, Andhra Pradesh INDIA 2005 - EF108205
47 A APS 68/05 Srikkakulam, Andhra Pradesh INDIA 2005 EF120403 EF108206
2.14 Similarity analysis and detection of recombination 
events
Similarity plots for Lpro sequences, complete P1 sequence 
and complete 1D sequence were performed using the 
Simplot software (Lole et al 1999) with windows 200 
bp in size (step: 20 bp) with gap stripping and Kimura 
2-parameter correction. Recombination events were 
detected by a bootscan of sequences under different genetic 
groups. Recombination events were also detected using the 
Datamonkey website (Pond and Frost 2005) by genetic 
analysis for recombination detection (GARD) analysis and 
by breakpoint placement support in the GARD analysis.
2.15 Selection pressure analysis
Positively selected sites (codon-specifi c analyses of dN/dS) 
were identifi ed using single likelihood ancestor counting 
(SLAC) analysis (Pond and Frost 2005), a modifi cation of 
the Suzuki–Gojobori method (Suzuki and Gojobori 1999) 
available at the Datamonkey website (Pond and Frost 2005). 
The analysis was done with the HKY85 substitution model 
on phylogenetic trees inferred using the NJ method with a 
cut-off P value of 0.1 as described by Klein et al (2006). 
Only those sites that showed dN–dS>0 with P<0.05 were 
considered as positively selected.
3. Results
3.1 Viruses
Forty-six FMD virus samples originating from various parts 
of India including vaccine strains were phylogenetically 
compared for their genetic relatedness. The fi eld samples 
were collected from the states of Andhra Pradesh (10); 
Gujarat (8); Tamil Nadu (5); Haryana and West Bengal 
(4), Maharashtra (3), Orissa and Uttar Pradesh (2 each) and 
Bihar, Jammu and Kashmir, and Meghalaya (1 each). The 
identity of two fi eld samples was not known. Vaccine strains 
of Indian origin, viz. A IND 17/82 (Himachal Pradesh), 
A IND 7/82 (Gujarat), A IND 17/77 (West Bengal), A 
IVRI and exotic strains A IRAQ 24/64, A
10
 HOLLAND 
42, A
5
 FRANCE 60 and A
24
 BRAZIL 55 (Carrillo et al 
2005) originating from Iraq, Holland, France and Brazil, 
respectively, were included for genetic comparison.
3.2 Genetic comparison of FMDV serotype A isolates
All the 46 viruses were isolated using BTy cell culture or 
directly using BHK-21 cell culture. Out of the 46 isolates, 
an LP12A region of ~3.0 kb size could be amplifi ed from 25 
isolates, P1 region of ~2.2 kb from 8 isolates and 1D region 
of ~700 bp from another 13 isolates used in the study. The 
RT-PCR products could be purifi ed and visualized using 
0.8% agarose gel with ethidium bromide staining.
3.3 Lpro coding region
The NJ tree and Bayesian tree, constructed using the Lpro 
coding nucleotide sequences (fi gure 1a and 1b) revealed the 
existence of isolates that were related to the A
22
 subtype and 
not the A
5
 or A
10
 subtypes, as thought earlier. The various 
FMDV serotype A isolates could be broadly classifi ed as 
being of South American, European, Euro-South American 
and Asian lineages. This fi nding indicates that the Indian 
isolates were derived from a single major lineage related 
to A
22
 represented by A
22 
IRAQ 24/64, and later diverged 
into different sublineages. Five major sublineages (L1, L2, 
L3, L4 and L5) could be recognized. The predominantly 
circulating sublineage L5 consisted of Indian isolates that 
emerged after 1994. Post-1995, the virus diverged into many 
groups and the latest of them were isolates from the state of 
Andhra Pradesh, A APS 44/05, A APS 50/05, A APS 55/05 
and A APS 66/05. None of the Indian isolates except ORS 
64/84 was related to the vaccine strain A IVRI. Incidentally, 
this vaccine strain was closely related to A
10
 HOLLAND 42. 
A signifi cant fi nding is that the Lpro region of A IND 57/79 
closely matched that of A IRAN 98, while A IND 19/76 and 
A IND 5/68 closely matched that of A IRAN 96.
3.4 Partial 1D region
Serotype A isolates of the world were grouped as European, 
Euro-South American, South American, African and Asian 
(tree not shown). The Asian group of viruses constitutes 
those predominantly of Middle Eastern origin and those 
from the Indian subcontinent. The virus strains from the 
Indian subcontinent have evolved into different genetic 
groups during the past 37 years and post-1995, serotype A 
viruses established themselves as the major genetic groups. 
Most of the circulating viruses had evolved from this 
lineage. The recent isolates of 2005 were categorized into a 
separate subgroup and were closely related to A IND 57/79. 
Based on the NJ tree analysis, the FMDV serotype A virus 
was divided into 13 distinct genetic groups (G-I to G-XIII) 
and the Indian isolates could be classifi ed under four genetic 
groups (G-IV, G-VI, G-VII and G-XII). The vaccine strain 
A IND 17/82 represents G-VI and A IND 17/77 was placed 
in G-IV. A IVRI was grouped with European isolates in G-I, 
which included A
10
 HOLLAND 42.
Vaccine strains A
24
 BRAZIL 55 represented the South 
American isolates (G-V). Further, the isolates of South 
American origin were categorized in three different genetic 
groups (G-I, G-II and G-V). A
22
 IRAQ 24/64 represented 
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Figure 1a. Dendrogram showing the relationship between type A Indian isolates based on nucleotides constituting the leader protease 
(Lpro ) region – neighbour-joining (NJ) tree.
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Figure 1b. Dendrogram showing the relationship between type A Indian isolates based on Bayesian analysis of nucleotides constituting 
the leader protease-coding sequence.
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Figure 2a. Dendrogram showing the relationship between type A Indian isolates based on neighbour-joining (NJ) analysis of nucleotides 
constituting the complete 1D sequence.
A4Germany72
A4Germany
A2Spain69
A1Germany71
A3Germany68
A10Holland42*
A5IVRI
ORS6484
A12UKG32
A17Brazil67
A135Brazil8
A18Venezuella67
A27Columbia67
A20USSR64
AItaly62
A5France60*
A5Germany51
A4Spain
A14Spain59
AArgentina61
A25Argentina59
AArgentina2001
AArgentinalop2001
AUruguay2001
AArgentina2000
APhillipines75
A29PeruU69
A32Venezuella70
ABrazil70
ABrazil77
ABrazil58
AColumbia85
A26Argentina66
A16Brazil59
A24Brazil55*
A21Kenya64
A15Thailand60
A IND268
A IND373
A IND1777*
A IND170
A28Turkey72
A22Iraq64*
A22Iraq170
AIran2299
AIran98
AIran196
A IND5779
RAJ2196
GUA2791
GUM3384
A2191
GUA2491
ORS7588
MAT1893
A IND876
APS4405
APS6805
MEU4903
HAH1400
APR5101
GUK1495
BIM4695
HAH5195
TNAn6094
MAN4794
TNC7194
100
100
100
73
100
100
100
100
100
100
99
100
100
60
96
100
100
100
99
98
93
100
99
62
83
99
96
71
100
88
47
83
87
31
49
35
33
53
30
28
50
76
97
24
98
21
48
74
86
14
14
12
15
46
57
66
32
30
27
45
69
39
18
22
0.02
Indian
Middle East Asian
Asian
Euro-South American
South American
European
Genetic analysis of foot-and-mouth disease virus serotype A of Indian origin 93
J. Biosci. 34(1), March 2009
Figure 2b. Dendrogram showing the relationship between type A Indian isolates based on Bayesian analysis of nucleotides constituting 
the complete 1D sequence.
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Figure 3. (A) Similarity plot for a type A Indian isolates showing a recombination event in the Lpro-coding region. (B) Recombination 
event in Lpro-coding region in a serotype A virus of Indian origin.
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the A
22
 strains (G-IV). The Middle-East Asian isolates were 
divided into six genetic groups – G-IV, G-VIII, G-IX, G-X, G-
XI and G-XII. Isolates from Thailand were grouped in G-VIII 
while the Chinese isolates represented G-III. G-IX consisted of 
isolates from Malaysia and Thailand identifi ed between 1993 
and 1997, while G-X consisted of isolates from Iran identifi ed 
in 1997 and 1998, which were different from G-XI. A IRAN 
96, A IRAN 98 and A TURKEY 2000 were included in G-XII 
while A IRAN 99 was included in G-XI. The recent variant of 
serotype A from the Middle East, A IRAN 2005, was included 
in G-VIII along with an earlier Iranian isolate, A IRAN 87 and 
isolates from Thailand. The recent Indian isolates (Andhra 
Pradesh) were distantly related to A IND 57/79 and A IND 
17/77, forming a distinct subgroup. The isolates of 2000, 
2001 and 2003 have a common ancestor that diverged in the 
year 1994 from the isolates of G-VI. Incidentally, the vaccine 
strain from Saudi Arabia, A SAU 25/87, was grouped with 
G-VI, which showed a close relationship with the Indian type 
A isolates of the 1980s and early 1990s. The African serotype 
A isolates formed a distinct genetic group not previously 
described (G-XIII), which included two distantly related 
isolates A
21
 KENYA 64 and A EGYPT 06.
3.5 Complete 1D region
Based on the NJ and Bayesian trees (fi gure 2a, b), the 
serotype A isolates from different parts of the world can 
be grouped as being of European, Euro-South American, 
South American, African and Asian origin as in the case of 
the partial 1D region phylogeny. The Asian group consisted 
predominantly of Middle-East Asian, Indian and a few 
South-East Asian type A isolates. 
Close examination revealed that there were only two 
major lineages and the viruses from the Indian subcontinent 
evolved over the years into different genetic groups. The 
virus post-1995 constituted the major or dominant genetic 
group and most of the circulating virus strains have evolved 
from this lineage. The genetic drift from the different 
vaccine strains used in the subcontinent was very high. The 
recent isolates of Iran (1996 and 1998) and Turkey (1998) 
were distantly related to A IND 57/79. Here again, only one 
Indian isolate A ORS 64/84 was related to A IVRI.
3.6 Similarity plot analysis and detection of recombina-
tion events
The similarity plot analysis of the Lpro coding region 
revealed a recombination event in at least one Indian isolate, 
A IND 20/82 by Simplot® analysis and boost scan analysis 
for recombination (fi gure 3a, b). This isolate was a chimera 
of two other isolates, A IND 16/82 and A IND 54/79. The 
recombination was confi rmed by GARD analysis and by 
breakpoint placement support in the GARD analysis. The 
isolates shared sequence similarity with A IND 16/82 at 
nucleotide positions 1–265 and 450–651, while at positions 
266–449 they shared sequence similarity with A IND 54/79.
Similarly, the isolate A RAJ 21/96 appeared to be a 
recombinant of A IVRI and A TNAn 60/94 in the 1D region 
of the P1 sequence. The Simplot® analysis and boost scan 
analysis for recombination (fi gure 4a, b) revealed that the 
recombination was in the VP1 coding 1D region. The 
GARD analysis and breakpoint placement support in the 
GARD analysis also confi rmed this recombination. The 
recombination had occurred between nucleotide positions 
1572 and 1956 of the P1 region. The isolates shared 
sequence similarity with A TNAn 60/94 at positions 1–1572 
and 1957–2211, while at positions 1573–1756 they shared 
sequence similarity with A IVRI.
3.7 Selection pressure analysis
3.7.1 Lpro coding region: Examination of the deduced 
amino acid sequences of the Lpro region for selective 
pressures revealed that 2 sites (residues 23 and 34) were 
positively selected (fi gure 5a). The positive selection at 
site 23 was signifi cant (P<0.05; 0.046) while at site 34 it 
was not signifi cant (P>0.05; 0.061). These residues were 
located close to the second initiation codon of the Lpro and 
are therefore exposed to factors infl uencing virus protein 
synthesis. The histories of these two residues show that at 
site 23, the codons AAA, TCA, ACA or CTA (Lys, Ser, Thr, 
Leu or Ser, respectively) were selected in place of ACA, 
CCA or TCA (Thr, Pro or Ser) and at site 34, the codon TAC 
(Tyr) was selected for CAC (His).
3.7.2 VP1 coding region: Examination of the deduced 
amino acid sequences of the VP1 coding region for selective 
pressures also revealed 2 sites (residues 154 and 171) that 
were positively selected (fi gure 5b). Residue 171 displayed 
signifi cant evidence of positive selection (P<0.01; 0.0031), 
while positive selection at residue 154 was not statistically 
signifi cant (P>0.05; 0.066). These two residues were located 
within the immunodominant GH-loop of the VP1 protein, 
which indicates the vulnerability of this region for mutation 
due to constant immune pressure. The history of these two 
residues shows that at site 171, the codons AAC, GAC, 
GCC, TCC, GGC or GTC (Asn, Asp, Ala, Ser, Gly or Val, 
respectively) were selected for ACC (Thr) and GCC (Ala), 
while at site 154, the codons GCG and ATC (Ala and Ile, 
respectively) were selected for GTG and GTC (Val).
4. Discussion
4.1 Phylogenetic analysis of sequences
FMDV is a positive-sense RNA virus and hence has 
error-prone replication (Sobrino et al 2001). It is therefore 
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Figure 4. (A) Similarity plot for a type A Indian isolates showing recombination event in the VP1 coding 1D region. (B) Recombination 
event in VP1 coding region in a serotype A virus of Indian origin.
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Figure 5. (A) Sliding window representing the rate of synonymous and non-synonymous nucleotide substitutions per site from serotype 
A Lpro-coding sequences. Zero value indicates dN = dS. (B) Sliding window representing the rate of synonymous and non-synonymous 
nucleotide substitutions per site from serotype A VP1 coding sequences. Zero value indicates dN = dS.
(A)
(B)
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not uncommon to observe virus isolates with different 
sequences present in a pool of viruses isolated from a 
single animal. However, all the virus isolates with different 
sequences do not survive and establish themselves in the 
environment due to selection pressure. Those that establish 
themselves result in newer strains that are genetically and 
antigenically different from the parent strain. As a result, 
single-type variants with varying antigenic make-up emerge 
in the fi eld from time to time. These isolates can cause 
outbreaks, despite the fact that a good inactivated vaccine 
against FMDV is available. 
The NJ and Bayesian trees, constructed using the Lpro 
coding nucleotide sequences revealed many sublineages that 
circulated in India between 1968 and 2005. All the isolates 
were related to the A
22
 subtype and none of the Indian strains 
showed a relationship to the A
5
 or A
10
 subtypes. The various 
FMDV serotype A isolates could be broadly classifi ed as 
belonging to the South American, European, Euro-South 
American and Asian lineages. The Indian isolates were derived 
from a single major lineage that diverged from the A
22
 strains 
represented by A
22 
IRAQ 24/64. Five sublineages (L1, L2, L3, 
L4 and L5) could be recognized. The sublineage L1 consisted 
of A IND 7/82; L2 consisted of A IND 85/79, A IND 86/79, A 
IND 2/68, A IND 20/82, A IND 22/82, A IND 26/82, A IND 
25/81 and ORS 75/88; L3 consisted of A IND 73/79, A GUM 
33/84, A APA 25/84 AND AA AP 41/84; L4 consisted of 
Indian isolates that emerged post-1994, namely, A TNAn 60/
94, A TNC 71/94, A BIM 46/95, A APS 44/05, A APS 50/05, A 
APS 55/05, A APS 66/05 and A APS 68/05; while L5 consisted 
of A IND 3/77, A IND 16/82, A IND 17/82. Sublineage L4 is 
the predominant circulating one. The virus post-1995 diverged 
into many groups and the latest are the isolates from the state 
of Andhra Pradesh. The results confi rmed the high variability 
of type A FMDV isolates in India.
Globally, FMDV type A is classifi ed into 10 major 
genotypes (genotypes I–X) based on the 1D (VP1) gene 
sequence with >15% nucleotide divergence among the 
genotypes (Tosh et al 2002a). Since then, more variant strains 
have emerged in different parts of the world and the present 
study identifi ed three more genotypes belonging to the A 
IRAN 96 and A IRAN 99 lineages from the Middle East, 
and A
21
 KENYA 64 and A EGYPT 06 from Africa. Earlier 
studies have shown that the Indian isolates have four distinct 
genotypes (Tosh et al 2002a). Examination of the complete 
1D region in the present study showed that most of the Indian 
isolates belong to only two major genetic lineages, though 
newer virus strains have appeared over time and appear to 
have evolved from existing Indian serotype A virus strains. 
Only one Indian isolate (A ORS 64/84) could be grouped with 
the vaccine strain A IVRI which, in turn, could be grouped with 
A
10
 HOLLAND 42. Similar fi ndings were reported by Tosh et 
al (2004) wherein the phylogenetic relationships between 35 
Indian type A FMDV isolates were reconstructed by Lb gene 
sequences using quartet-puzzling steps. The possibility of the 
virus originating from outbreaks in animals that had been 
administered a vaccine containing partially or incompletely 
inactivated virus could not be ruled out. Outbreaks due 
to escape of live virus in vaccine preparations have been 
documented earlier (King et al 1981). In P1 phylogeny, the 
genotype distinctions were supported by bootstrap values 
≥98 of the 1000 bootstrap replicates. However, as reported 
by Tosh et al (2002a), IND 17/77 (genotype IV) was 
supported by low bootstrap values that could be due to limited 
phylogenetic information on related viruses. The probable 
extinction of genotype IV was the explanation provided, 
since none of the isolates were grouped with genotype IV 
in both the phylogenies. Further, the isolates were clustered 
into distinct genetic subgroups (<5% divergence) within 
genotypes VI and VII. Examination of the P1 phylogeny 
(phylogenetic trees not shown) showed temporal grouping 
patterns of the isolates rather than geographical clustering 
within subgenotypes, indicating their widespread distribution. 
This geographical intermixing of isolates could be due to 
unrestricted animal movement in the country. Partial vaccine 
coverage, indiscriminate movement of cattle within India and 
involvement of small ruminants in the epidemiology might 
have contributed to the distinct evolutionary pattern in India. 
Similar fi ndings have been reported by Araujo et al (2002), 
wherein a high degree of genetic and antigenic variability was 
seen among the strains of serotype A FMDV isolated from 
foci of FMD in Brazil in 1994 and 1995. Such variability was 
particularly evident when these viruses were compared with 
the A
24
 BRAZIL 55 strain.
Recently, in a study related to the Turkish type A isolates, 
Klein et al (2006) reported the presence of two independent 
lineages among the currently circulating Turkish isolates. 
These isolates are closely related to the two earlier identifi ed 
lineages of Iranian origin, A IRAN 96 and A IRAN 99 
along with the traditional A
22
 subtype viruses based on 
phylogenetic analysis. These two new lineages have also 
been reported from Iran and other Middle-East countries. A 
fourth lineage was reported in the year 2005, which diverged 
from the A
22
 virus subtype and is antigenically related to the 
A
22
 IRAQ 24/64 and A
22
 Mahmattli strains.
Comparison of deduced amino acid consensus sequences 
for the P1 region of the different type A viruses showed 
genotype-specifi c amino acid substitutions, which confi rm 
the earlier fi ndings of Tosh et al (2002a). For instance, the 
variations at 8 amino acid positions (VP2 134, 191, 195, VP3 
197, VP1 43, 83, 141 and 149) in the P1 region shown earlier 
were confi rmed as characteristics of the Indian isolates 
belonging to genotypes IV, VI and VII. Of the 8 positions, 
6 were mapped to/near antigenically critical residues. The 
highest variability was found not only at the amino acid 
positions corresponding to the main immunogenic region 
of the FMDV capsid, the G-H loop (amino acid residues 
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130–160), but also in other amino acid residues of the VP1 
molecule, especially in sequences 40–47 and 164–171. 
Thomas et al (1988) described in VP1 another antigenic site 
constituted by the residues around the amino acid 170 (H-I 
loop). Apart from this, relevant modifi cations in the amino 
acid sequences 43–47 and in the residue 174 of VP1 were 
reported in the A ARG 76 and A ARG 79 strains (Cheung et 
al 1984; Weddel et al 1985).
4.2 Reverse mutation or convergent evolution?
The current study throws some light on the reverse mutation 
in FMDV or convergent evolution of viruses that are 
separated by geography and time. Genetic comparison of 
the Lpro and VP1 coding sequences of A IRAN 96 and A 
IRAN 98 reveal that these two isolates are related to one of 
the earliest vaccine strains A IND 57/79. The similarity of 
the sequences may be due to the extensive mutations that 
occurred in these two isolates, which reverted to those isolates 
that were in circulation earlier rather than being introduced 
from outside sources. However, the VP1 and Lpro trees show 
non-congruous results and it is only in the VP1 tree that the 
Middle Eastern and A IND 57/79 viruses look similar. This 
suggests a common origin for these Middle East Asian and 
Indian viruses, perhaps due to a recombination event or due 
to back mutations in VP1. The current WRL reports reveal 
that the outbreaks of 2005 in Iran and Turkey were caused by 
isolates that were different from both A IRAN 96 and A IRAN 
99 but similar to A
22
 IRAQ 64 (WRL-FMD Network Report 
2006), and this could be an evidence for reverse mutations or, 
more likely, convergent evolution. This may be due to vaccine 
pressure and re-emergence of old virus strains. However, it 
must be noted here that A IRAN 99 does not relate to A IND 
57/79 or any of the Indian isolates, at least on comparison 
of the VP1 coding sequences, though it belongs to the same 
geographical area as the other Middle East Asian isolates.
4.3 Recombination events in Lpro and P1 regions
Recombination events have been documented in the 3’ 
end of the genomes encoding the non-structural proteins 
of picornavirus (Cammack et al 1988; Wilson et al 1988; 
Furione et al 1993; Santti et al 1999). Until recently, there 
was only one report available on recombination within the 
FMDV coat proteins involving isogenic parents (King et 
al 1982). The report of Tosh et al (2002b) provided direct 
evidence of recombination in the structural protein-coding 
region in type A FMDV involving two heterogenic parents. 
One Indian serotype A isolate A IND 170/88 was discovered 
as a recombinant of genotypes VI and VII that circulated 
in India. Recombination, particularly in the structural 
protein-coding region, may provide selective advantage to 
the virus, as the pre-existing immunity towards either of the 
parental viruses may not afford complete protection. This is 
of particular concern in countries where multiple FMDV 
genotypes co-circulate (Tosh et al 2002b). In our study, 
we found that recombination can also occur at the 5’ end of 
the virus, which includes the Lpro coding region. However, 
the progenies of the isolate A IND 20/82 failed to establish 
themselves into separate genetic groups over a period of 
time. Also, the recombination event in the VP1 region of 
isolate A RAJ 21/96 showed that recombination can occur 
at any place in the genome. However, it was not necessary 
that such recombinant virus strains could become ancestors 
to form a distinct genetic group. Moreover, this isolate was 
not neutralized by any of the reference vaccine sera except 
rabbit convalescent sera raised using A TNAn 90/94. This 
could be due to a sharing of the immunodominant sites that 
are present in the VP1, VP2 and VP4 regions but not in the 
VP3 region, which matched with A IVRI and A ORS 64/84.
4.4 Positive selection
Studies based on monoclonal antibody-resistant mutants 
have identifi ed 36 amino acid sites that are critical in the 
antigenicity of FMDV type A (Thomas et al 1988; Baxt et al 
1989; Bolwell et al 1989; Saiz et al 1991). Mittal et al (2005) 
identifi ed six additional sites. In this paper, we report another 
site (171 in VP1) that is under positive selection. Incidentally, 
this site is present within the major immunodominant 
site or the antigenic epitope within the G-H loop and is a 
conformation-dependent site. However, positive selection 
of site 154 described by earlier workers (Tosh et al 2003) 
was not signifi cant (P>0.05) in our study. This could be 
due to the epidemiological nature of the disease and the 
distinct evolutionary pattern that different virus strains in 
India underwent. Aggarwal and Barnet (2002) found that 
the antigenic sites reported are far from complete, and yet-
unidentifi ed sites might also be important in the induction 
of a protective immune response. Importantly, some of 
these sites may be present in and around the loop region of 
structural capsid proteins such as 171, which was signifi cant 
in the Indian isolates compared. It was previously proposed, 
through amino acid sequence alignments, that Lpro of FMDV 
belongs to the family of cysteine proteinases (Gorbalenya et 
al 1991). Recently, the crystal structure of the FMDV Lpro 
from O1Kaufbeuren was determined (Guarné et al 1998, 
2000), confi rming Cys51 and His148 to be the catalytic 
residues as well as the papain-like fold. As expected, the 
catalytic triad of the proteinase (Cys52–His149–Asp164) 
was conserved. In this study, no difference was found in the 
length of Lpro. However, it has been reported that in type A 
isolates from Kenya, namely, KEN/37/84 and KEN/1/76, the 
leader proteinase Lpro was found to be 202 and 201 amino 
acids in length, respectively. All the European type A, O and 
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C isolates had 201 amino acids. The corresponding region 
of the SAT serotypes, and the type A and O isolates from 
West Africa had 199 residues. The most variable regions in 
Lpro were found to be a-helices 2 and 3, b4, the loop to b5 
as well as the C-terminal extension (CTE). The evidence 
for positive selection in the Lpro region indicates that the 
immune mechanisms are active even at the Lpro region where 
the viral protein initiation sites are present. The viruses 
circulating in these regions are under immune pressure in 
some part of their evolutionary path due to a low level of 
antibodies. Therefore, antibody-combining sites are more 
likely to be under positive selection due to immune pressure 
(Tosh et al 2003); however, positive selection in the Lpro 
region identifi ed in this study shows that some intracellular 
selection pressure is in operation for the initiation of viral 
replication in the host. Such a selection may be responsible 
for selective binding of the ribosome for initiation of virus 
protein synthesis resulting in the generation of virus that 
can cause clinical signs even in vaccinated animals. Such a 
hypothesis needs to be confi rmed using in vitro studies using 
modifi ed Lpro sequences encoding these changes in the amino 
acid sequences. The signifi cance of positive selection on 
residue 23 is important as it is close to the second initiation 
codon (AUG) in the open reading frame (ORF) of the viral 
genome, as most of the viral proteins are said to be initiated 
from the second initiation codon in FMDV to produce Lb 
predominantly rather than using the fi rst initiation codon in 
the ORF to synthesize Lpro.
References
Aggarwal N and Barnett P V 2002 Antigenic sites of foot-and-
mouth disease virus (FMDV): an analysis of the specifi cities of 
anti-FMDV antibodies after vaccination of naturally susceptible 
host species; J. Gen. Virol. 83 775–782
Araujo J P Jr, Montassier H J and Pinto A A 2002 Extensive 
antigenic and genetic variation among foot-and-mouth disease 
type A viruses isolated from the 1994 and 1995 foci in Sao Paulo 
Brazil; Vet. Microbiol. 84 15–27
Arrowsmith A E 1975 Variation among strains of type A foot-and-
mouth disease virus in the Eastern Mediterranean region; J. 
Hyg. (London) 75 387–97
Armstrong R M, Samuel A R, Carpenter W C, Kant R and Knowles 
N J 1994 A comparative study of serological and biochemical 
methods for strain differentiation of foot-and-mouth disease 
type A viruses; Vet. Microbiol. 39 285–298
Azad H M, Srinivasan V A and Crowther J R 1995 Serological 
study of type A Indian foot-and-mouth disease virus isolates; 
Acta Virol. 39 193–196
Baxt B, Vakharia V, Moore D M, Franke A J and Morgan D O 1989 
Analysis of neutralizing antigenic sites on the surface of type 
A12 foot-and-mouth disease virus; J. Virol. 63 2143–2151
Belwal L M, Palanisamy R, Nagaiah K, Kalanidhi A P, Jagannatha 
M, Ramanna B C and Srinivasan V A 1986 Serological study of 
foot and mouth disease virus type A in India; Rev. Sci. Tech. Off. 
Int. Epiz. 5 723–730
Belwal L M, Kalanidhi A P, Nagaiah K, Ramanna B C and 
Srinivasan V A 1987 Immuno-serological studies on a foot and 
mouth disease virus type A strain involved in breakdown of 
vaccine immunity; Rev. Sci. Tech. Off. Int. Epiz. 6 115–126 
Bolwell C, Brown A L, Barnett P V, Campbell R O, Clarke B E, 
Parry N R, Ouldridge E J, Brown F and Rowlands D J 1989 Host 
cell selection of antigenic variants of foot-and-mouth disease 
virus; J. Gen. Virol. 70 45–57 
Cammack N, Phillips A, Dunn G, Patel V and Minor P D 1988 
Intertypic genomic rearrangements of poliovirus strains in 
vaccines; Virology 167 507–514
Carrillo C, Tulman E R, Delhon G, Lu Z, Carreno A, Vagnozzi A, 
Kutish G F and Rock D L 2005 Comparative genomics of foot-
and-mouth disease virus; J. Virol. 79 6487–6504 
Cheung A, Whitehead P, Weiss S and Kupper H 1984 Nucleotide 
sequence of the VP1 gene of the foot-and-mouth disease virus 
strain A Venesclau; Gene 30 241–245
Freshney R I 2004 Primary culture; in Culture of animal cells: 
a manual of basic technique (New Jersey: John Wiley) pp 
158–169
Furione M, Guillot S, Otelea D, Balanant J, Candrea A and Crainic R 
1993 Polioviruses with natural recombinant genomes isolated from 
vaccine-associated paralytic poliomyelitis; Virology 196 199–208
Gorbalenya A E, Koonin E V and Lai M M 1991 Putative 
papain-related thiol proteases of positive-strand RNA viruses. 
Identifi cation of rubi- and aphthovirus proteases and delineation 
of a novel conserved domain associated with proteases of rubi- 
alpha- and coronaviruses; FEBS Lett. 288 201–205
Grubman M J and Baxt B 2004 Foot-and-mouth disease; Clin. 
Microbiol. Rev. 17 465–493
Guarné A, Hampoelz B, Glaser W, Carpena X, Tormo J, Fita I and 
Skern T 2000 Structural and biochemical features distinguish 
the foot-and-mouth disease virus leader proteinase from other 
papain-like enzymes; J. Mol. Biol. 302 1227–1240
Guarné A, Tormo J, Kirchweger R, Pfi stermueller D, Fita I and 
Skern T 1998 Structure of the foot-and-mouth disease virus 
leader protease: a papain-like fold adapted for self-processing 
and eIF4G recognition; EMBOS J. 17 7469–7479 
Hamblin C, Armstrong R M and Hedger R S 1984 A rapid enzyme-
linked immunosorbent assay for the detection of foot-and-mouth 
disease virus in epithelial tissues; Vet. Microbiol. 9 443–435
Huelsenbeck J P and Ronquist F 2001 Mr.Bayes: Bayesian 
inference of phylogeny; Bioinformatics 17 754–755
Jangra R K, Tosh C, Sanyal A, Hemadri D and Bandyopadhyay S K 
2005 Antigenic and genetic analyses of foot-and-mouth disease 
virus type A isolates for selection of candidate vaccine strain 
reveals emergence of a variant virus that is responsible for most 
recent outbreaks in India; Virus Res. 112 52–59
King A M Q, McCahon Q, Slade D and Newman J W I 1982 
Biochemical evidence of recombination within the unsegmented 
RNA genome of Aphthovirus; J. Virol. 41 66–77
King A M Q, Underwood B O, McCahon D, Newman J W I and 
Brown F 1981 Biochemical identifi cation of viruses causing the 
1981 outbreaks of foot-and-mouth disease in the UK; Nature 
(London) 293 479–480
Klein J, Parlak U, Ozyoruk F and Christensen L S 2006 The molecular 
epidemiology of foot-and-mouth disease virus serotypes A and O 
from 1998 to 2004 in Turkey; BMC Vet. Res. 4 35
Genetic analysis of foot-and-mouth disease virus serotype A of Indian origin 101
J. Biosci. 34(1), March 2009
Knowles N J and Samuel A R 1995 Polymerase chain reaction 
amplifi cation and cycle sequencing of the 1D (VP1) gene of foot-
and-mouth disease virus. Report on Session of Research Group’s 
Standing Technical Committee of European Commission for the 
Control of FMD (Austria: FAO) pp 45–53
Kumar S, Tamura K and Nei M 2004 MEGA3: integrated software 
for molecular evolutionary genetics analysis and sequence 
alignment; Brief. Bioinfo. 5 150–163
Lole K S, Bollinger R C, Paranjape R S, Gadkari D, Kulkarni S S, 
Novak N G, Ingersoll R, Sheppard H W and Ray S C 1999 Full-
length human immunodefi ciency virus type 1 genomes from 
subtype C-infected sero converters in India with evidence of 
inter subtype recombination; J. Virol. 73 152–160
Mittal M, Tosh C, Hemadri D, Sanyal A and Bandyopadhyay S 
K 2005 Phylogeny genome evolution and antigenic variability 
among endemic foot-and-mouth disease virus type A isolates 
from India; Arch. Virol. 150 911–928
Mohapatra J K, Sanyal A, Hemadri D, Tosh C, Sabarinath G P and 
Venkataramanan R 2002 Sequence and phylogenetic analysis of 
the L and VP1 genes of foot-and-mouth disease virus serotype 
Asia1; Virus Res. 87 107–118
Mohapatra J K, Hemadri D, Rao T V, Sreenivasa B P, Subramaniam 
S, Sanyal A, Periyasamy T R, Singh N K, Pattnaik B and 
Venkataramanan R 2008 Assessment of suitability of two 
serotype A candidate vaccine strains for inclusion in FMD 
vaccine in India; Vet. Microbiol. 131 65–72
Nagendrakumar S B, Mythili T, Maroudam V, Madhanmohan M, 
Thiagarajan D and Srinivasan V A 2006 Comparison of different 
methods of routine typing of Indian isolates of foot-and-mouth 
disease virus; Acta Virol. 50 279–280
Page R D M 1996 TREEVIEW: an application to display 
phylogenetic trees on personal computers; Comput. Appl. 
Biosci. 12 357–358
Pond S L and Frost S D 2005 Datamonkey: rapid detection of 
selective pressure on individual sites of codon alignments; 
Bioinformatics 21 2531–2533
Roberts P J and Belsham G J 1995 Identifi cation of critical amino 
acids within the foot-and-mouth disease virus leader protein a 
cysteine protease; Virology 213 140–146
Sabarinath G P 2001 Comparison of nucleotide sequence of 
structural protein encoding (P1) region of foot-and-mouth 
disease virus serotype O isolates; MVSc thesis, Indian 
Veterinary Research Institute, Izatnagar, India
Saiz J C, Gonzalez M J, Borca M V, Sobrino F and Moore D 
M 1991 Identifi cation of neutralizing antigenic sites on VP1 
and VP2 of type A
5
 foot-and-mouth disease virus defi ned by 
neutralization-resistant variants; J. Virol. 65 2518–2524
Samuel A R and Knowles N J 2001 Foot-and-mouth disease 
type O viruses exhibit genetically and geographically distinct 
evolutionary lineages (topotypes); J. Gen. Virol. 82 609–621
Santti J, Hyypia T, Kinnunen L and Salminen M 1996 Evi-
dence of recombination among enteroviruses; J. Virol. 73 
8741–8749
Sobrino F, Sa´iz M, Jiménez-Clavero M A, Nún˜ez J I, Rosas 
M F, Baranowski E and Ley V 2001 Foot-and-mouth disease
virus: a long known virus but a current threat; Vet. Res. 32 
1–30
Suzuki Y and Gojobori T 1999 A method for detecting positive 
selection at single amino acid sites; Mol. Biol. Evol. 16
1315–1328
Thomas A A, Woortmeijer R J, Puijk W and Barteling S J 1988 
Antigenic sites on foot-and-mouth disease virus type A10; J. 
Virol. 62 2782–2789 
Thompson J D, Higgins D G and Gibson T J 1994 CLUSTAL W 
18x: improving the sensitivity of progressive multiple sequence 
alignment through sequence weighting positions-specifi c gap 
penalties and weight matrix choice; Nucleic Acids Res. 22 
4673–4680 
Tosh C, Hemadri D, Sanyal A and Bandyopadhyay S K 2003 
Genetic and antigenic analysis of two recently circulating 
genotypes of type A foot-and-mouth disease virus in India: 
evidence for positive selection in the capsid-encoding genes; 
Arch. Virol. 148 853–869
Tosh C, Sanyal A, Hemadri D and Venkataramanan R 2002a 
Phylogenetic analysis of serotype A foot-and-mouth disease 
virus isolated in India between 1977 and 2000; Arch. Virol. 147 
493–513
Tosh C, Hemadri D and Sanyal A 2002b Evidence of recombination 
in the capsid-coding region of type A foot-and-mouth disease 
virus; J. Gen. Virol. 83 2455–2460
Tosh C, Mittal M, Sanyal A, Hemadri D and Bandyopadhyay S 
K 2004 Molecular phylogeny of leader proteinase gene of type 
A of foot-and-mouth disease virus from India; Arch. Virol. 149 
523–536
Vangrysperre W and de Clercq K 1996 Rapid and sensitive 
polymerase chain reaction based detection and typing of foot-
and-mouth disease virus in clinical samples and cell culture 
isolates combined with a simultaneous differentiation with 
other genomically and/or symptomatically related viruses; Arch. 
Virol. 141 331–344
Vosloo W, Knowles N J and Thomson G R 1992 Genetic 
relationships between southern African SAT-2 isolates of foot-
and-mouth disease virus; Epidemiol. Infect. 109 547–558
Weddell G N, Yansura D G, Dowbenko D J, Hoatlin M E, Grubman 
M J, Moore D M and Kleid D G 1985 Sequence variation in 
the gene for the immunogenic capsid protein VP1 of foot-and-
mouth disease virus type A; Proc. Natl. Acad. Sci. USA 82 
2618–2622
Wilson V, Taylor P and Desselberger U 1988 Crossover regions 
in foot-and-mouth disease virus (FMDV) recombinants 
correspond to regions of high local secondary structure; Arch. 
Virol. 102 131–139
WRL-FMD Network Report 2006 Annual OIE/FAO FMD 
Reference Laboratory Network Report; http://wwwwrlfmdorg/
fmd_network/FMD%20Network%20Report%202006pdf
MS received 14 July 2008; accepted 16 October 2008
ePublication: 29 January 2009
Corresponding editor: SHAHID JAMEEL
